Keywords: European Commission, Pfizer, Xiapex, Dupuytren's. Britsol-Myers Squibb, Baraclude, Hepatitis B

European Commission clears Pfizer’s Dupuytren’s drug Xiapex and added use for Bristol-Myers’ Baraclude

Article | 02 March 2011

Print This

There were two pieces of positive news from the European Commission this week, as it gave final approval for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in